14 results
DEF 14A
AUPH
Aurinia Pharmaceuticals Inc
10 May 21
Definitive proxy
4:06pm
and a member of the board of directors of Histogenics Corporation, a regenerative medicine company. From 2006 to 2013, Peter was employed by Medlmmune
10-K/A
zi2fe9ys sap7
30 Apr 21
Annual report (amended)
4:16pm
PRE 14A
zg3baz3jbtu d8f1yr
27 Apr 21
Preliminary proxy
4:32pm
6-K
EX-99.3
l5e4bi
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
40-F
EX-99.3
si1i4fi eucea9t
5 Mar 20
Annual report (Canada)
4:06pm
40-F
EX-99.1
9unlisvwom3k2zt03zb
5 Mar 20
Annual report (Canada)
4:06pm
6-K
EX-99.3
8stpm hsj
6 Aug 19
Current report (foreign)
4:06pm
6-K
EX-99.2
y5hhj5odfz hpru
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
EX-99.2
nn4d9
14 May 19
Current report (foreign)
4:04pm
6-K
EX-99.1
6gi iravkc
11 Apr 19
Aurinia Pharmaceuticals Inc. 6-K
4:39pm
- Prev
- 1
- Next